Lixte Biotechnology Announces a Clinical Trial Agreement with Moffitt Cancer Center to Initiate Phase 1b/2 Trial Evaluating the Safety and Efficacy of LB-100 in Treatment of Patients with Low or Intermediate-1 Risk Myelodysplastic Syndrome
FPX Nickel Receives Multi-Year Area-Based Permit and Commences 2025 Drilling Activities at Baptiste Nickel Project
